Early evaluation of tumor response using contrast-enhanced ultrasonography for hepatocellular carcinoma treated with Solafenib.
Phase of Trial: Phase IV
Latest Information Update: 23 May 2014
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 05 Feb 2013 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by University Hospital Medical Information Network - Japan record.
- 25 May 2011 New trial record